2018
DOI: 10.1016/j.ijpharm.2018.09.053
|View full text |Cite
|
Sign up to set email alerts
|

Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
49
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 71 publications
(53 citation statements)
references
References 40 publications
4
49
0
Order By: Relevance
“…Only the formulation prepared combining αCD 4%/βCD 3% increased the apparent solubility of ACV (36.0 mg/mL, 0.16 M). This means that ACV was not prone to be encapsulated in PF127 polymeric micelles in agreement with studies carried out with other amphiphilic copolymers [48].…”
Section: Phase Solubility Studiessupporting
confidence: 89%
See 1 more Smart Citation
“…Only the formulation prepared combining αCD 4%/βCD 3% increased the apparent solubility of ACV (36.0 mg/mL, 0.16 M). This means that ACV was not prone to be encapsulated in PF127 polymeric micelles in agreement with studies carried out with other amphiphilic copolymers [48].…”
Section: Phase Solubility Studiessupporting
confidence: 89%
“…Only the formulation prepared combining αCD 4%/βCD 3% increased the apparent solubility of ACV (36.0 mg/mL, 0.16 M). This means that ACV was not prone to be encapsulated in PF127 polymeric micelles in agreement with studies carried out with other amphiphilic copolymers [48]. Inclusion complex formation of ACV with CDs, although feasible, has been reported to cause minor enhancements in apparent solubility [49].…”
Section: Phase Solubility Studiessupporting
confidence: 86%
“…They also evaluated the ocular toxicity and corneal permeability at EU Reference Laboratory following US Interagency Coordinating Committee. [36,37]. J.…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…(Asteraceae), increasing its solubility and its intestinal permeability [21]. Other applications described the use of Soluplus for doxorubicin delivery in the treatment of resistant tumors [20] or to increase acyclovir permeability across the cornea and sclera [22] or even to enhance oral bioavailability and hypouricemic activity of scopoletin [23]. Numerous other applications are described in the literature [24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%